Home > Neurology > ECF 2020 > ECF Round-Up Articles > Novel disease-specific scale confirms huge impact of fatigue

Novel disease-specific scale confirms huge impact of fatigue

Presented By
Marion Azoulai, Carenity, France
Conference
ECF 2020
A real-world study in US adults with relapsing multiple sclerosis (MS) confirmed that fatigue has a huge impact on day-to-day functioning in most patients with relapsing MS. Fatigue increases with symptom exacerbation, depression, sleep disorders, and pain. The Fatigue Symptoms and Impacts Questionnaire-Relapsing Multiple Sclerosis (FSIQ-RMS) is a novel MS-specific assessment that can advance the understanding and management of fatigue. Fatigue is defined by subjective experience and measured via patient-reported outcome (PRO) instruments. PRO tools that are MS-specific can improve understanding of MS fatigue and its impact, improving its clinical management. However, currently available PROs that assess MS-related fatigue do not meet instrument development and psychometric property requirements based on current guidelines. The FSIQ-RMS is a novel MS-specific PRO instrument, which was developed to assess both fatigue in patients with relapsing MS a...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on